Weight Loss

Novo Nordisk, a Danish pharmaceutical company, has been suspended from the UK’s pharma trade body for not being transparent in its promotion of its weight-loss predecessor, liraglutide, to doctors. The company is currently involved in a study that found that its weight-loss drug semaglutide reduces the risk of heart attacks, Continue Reading